Background Sub-Saharan Africa (SSA) has a disproportionate burden of both infectious and chronic diseases compared with other world regions. Current disease estimates for SSA are based on sparse data, but projections indicate increases in non-communicable diseases (NCDs) caused by demographic and epidemiologic transitions. We review the literature on NCDs in SSA and summarize data from the World Health Organization and International Agency for Research on Cancer on the prevalence and incidence of cardiovascular diseases, diabetes mellitus Type 2, cancer and their risk factors.
Introduction
There is a rising epidemic of non-communicable diseases (NCDs) in sub-Saharan Africa (SSA), that includes cardiovascular disease (CVD), cancer and metabolic diseases such as diabetes and obesity. [1] [2] [3] [4] Due to the historic focus on maternal-child health and infectious diseases in SSA, much less research has been conducted on NCDs. However, as in other low-and middle-income regions, individuals in SSA suffer from the dual burdens of infectious diseases and NCDs. 5, 6 Far from being diseases exclusively of the wealthy, NCDs are already, and will continue to be, a significant burden on the world's poor. The epidemiological transition from predominantly infectious to NCDs is already well underway in many low-and middleincome countries, as it is in SSA. In 2004, more than half of all deaths in SSA were caused by infectious conditions, and one-quarter by NCDs (Table 1) ; by 2030, NCDs will cause 46%. 7 Global Burden of Disease studies suggest that the age-standardized death rates from NCDs is higher in at least four SSA countries (Democratic Republic of the Congo, Nigeria, Ethiopia and South Africa) than in highincome countries. 8 A study in Tanzania also showed that death rates from NCDs are higher in all age groups between 15 and 59 years than in high-income countries. 9 This burgeoning epidemic of NCDs has several root causes. Decreases in communicable diseases, which disproportionately affect children, lead to greater survival into adulthood and a relative aging of the population. This changing demographic profile of the SSA population is an important factor influencing the future incidence of NCDs in Africa. Currently, the population pyramid of most African countries is cone shaped, with a large base of young people and the median age <20 years, compared with high-income countries where it is usually closer to a cylinder and the median age is 440 years. Population dynamics suggest that the at-risk population for NCDs is likely to increase at a significant rate in SSA compared with high-income countries. 10 While age in of itself is important, the relevant exposure is the life-course accumulation of risk factors that is afforded by longevity. 11, 12 Even standardized for age, mortality from NCDs in SSA is projected to increase dramatically in the coming years ( Figure 1 ).
Additional drivers of these epidemics are urbanization and changes in lifestyle associated with economic development. [13] [14] [15] These include changes in (i) diet, (ii) physical activity, (iii) smoking, (iv) adiposity and (v) alcohol use. In high-income countries, 90% of all new diabetes mellitus cases and 70-80% of all new CVD cases are attributable to relatively modest differences in these lifestyle factors. [16] [17] [18] Similarly, the INTERHEART study that included nine African nations and 43 other countries found that five risk factors (smoking, hypertension, abdominal obesity, diabetes mellitus and elevated ApoB/ApoA-1 ratio) accounted for 90% of the risk for a first myocardial infarction in the African sites. 14, 19 Other social and environmental changes in SSA also likely play a role such as changes in air quality and early childhood exposures. 15, 20 These lead to increased prevalence of NCD risk factors such as hypertension, abdominal obesity and abnormal blood lipids. 1, 15, 20 If action is not taken, one estimate shows that US$84 billion in lost productivity could occur due to heart disease, stroke and diabetes in the 23 low-and middle-income countries (four of which are in SSA), which would account for 80% of worldwide NCD mortality by 2015. 8 Thus, NCDs represent a largely 'silent' epidemic in SSA. We review the literature and summarize World Health Organization (WHO), and International Agency for Research on Cancer (IARC) data on NCDs in SSA with the goal of reporting on the burden of NCDs measured by morbidity and mortality and the prevalence of NCD risk factors.
Due to the large scope, we were not able to address neuropsychiatric diseases and chronic lung diseases.
Methods
We searched the Medline database using National Library of Medicine Medical Subject Heading (MeSH) search terms to cover each condition. These were 'heart diseases', 'stroke', 'diabetes mellitus type 2' and 'Neoplasms not Benign Neoplasms' combined with the term 'Africa south of the Sahara'. We used the limit function to limit search results to articles in English and to human studies. In order to identify studies reporting prevalence, incidence and mortality of each condition, we repeated the search excluding review articles (MeSH NOT 'Review'). Data were extracted using a standard form (S.D. extracted data on heart diseases, stroke and cancer, J.J.B. extracted data on diabetes mellitus type 2). We also consulted articles listed in references of retrieved articles and from discussions with colleagues with SSA experience.
Our inclusion criteria were community-based studies conducted in any SSA country that reported on disease or risk factor prevalence, incidence or mortality for each of the key diseases in our investigation (heart diseases, stroke, diabetes mellitus type 2 and cancer). We excluded hospital-based studies as they are not representative of the general population because of widespread lack of health-care access. Hospital-based studies were used to extract data on diabetes mellitus complications. Due to the comparatively small number of studies we did not use criteria for evaluating the quality of the study. We did not restrict our search to specific dates, and made every attempt to obtain older articles (for example, those published in the 1960s and 1970s). We read at a minimum each abstract to screen for relevance, and read in full those which met our inclusion criteria. We also analysed publicly available WHO Global Burden of Disease and WHO STEPS data sets on estimated and projected causes of death for different world regions and prevalence of diabetes mellitus in SSA. We analysed the International Agency for Research on Cancer (IARC) public databases for cancer incidence and projections for SSA.
Results
Search results for cardiac diseases excluding review papers returned 1494 manuscripts, 1201 of which were in English and limited to human studies dating from 1965. The stroke search yielded 149 manuscripts; 127 met the criteria for language and human studies. Diabetes mellitus search results were 348 overall, with 321 in English and humans. The reported prevalence of heart diseases, stroke and diabetes mellitus from community-based studies are provided in Tables 2-4 ; all numbers are for crude prevalence unless otherwise noted. Crude and age-standardized cancer incidence from five cancer registries included in the IARC database are presented in Table 7 .
Commonly reported risk factors in the literature from community-based studies of CVDs in SSA are reported in Table 5 ; hypertension, smoking and obesity were the most frequently reported. Half (50%) of these studies were conducted in South Africa. Alcohol use, hypercholesterolaemia and sedentary behaviour were infrequently measured. 
Cardiac diseases
Cardiac diseases and their risk factors are increasing in SSA. 2, 13, 21 Our review of the literature showed that the prevalence of cardiac diseases, excluding congenital diseases, differed considerably between countries and disease type, ranging from 0.1% for coronary events in Sudan to 20% for endomyocardial fibrosis in rural Mozambique (Table 2 ). In adults aged 560 years, ischaemic heart disease is already the leading cause of death among men and is second among women. 2 The most important risk factors described in one large case-control study of non-fatal 14 The behavioural and social determinants of these risk factors are also important. Higher income, education, urban living and psychosocial stress each appear to be associated with increased risk of myocardial infarction or its risk factors in SSA. 13, 14, 22 However, the underlying determinants of these changes are poorly quantified in most SSA countries (Table 5) .
While few non-hospital-based studies of cardiac disease risk factors in adults have been conducted in SSA, hypertension prevalence ranged from 6 to 48% overall, and was high in both urban and rural South Africa (Table 5 ). In both urban and rural locations of Tanzania, Nigeria and Ghana hypertension was in double digits, and in the Democratic Republic of Congo was in an urban setting. Obesity ranged from 0.4% in rural Tanzania to 34% among Black South African women. Smoking prevalence is high among adults in South Africa, ranging from 28 to 71% among men and 7 to 40% among women in studies reporting values for the general population or different sub-populations. Although other countries reported lower smoking prevalence, in Ethiopia and rural Tanzania it was 12 and 26% among men (Table 5 ). These figures of disparate and likely increasing prevalence of NCD risk factors could be illustrative of changing situations that may be occurring among other groups and in other countries, but for which there is not reliable data.
Africa is additionally burdened by rheumatic heart disease, HIV and other infections that impact cardiovascular outcomes. [23] [24] [25] For example, while tuberculosis accounts for <5% of cases of pericarditis in high-income countries, it causes 450% of cases in low-and middle-income countries, 26 and its incidence is rising sharply due to the HIV epidemic. 24 Of all childhood rheumatic heart disease cases worldwide, 42% occur in SSA. 27 Large studies of school children conducted in many SSA countries since the 1970s have shown prevalence of rheumatic heart disease ranging from 0.2 to 3%. 23, [28] [29] [30] [31] [32] Yet, few countries collect systematic data needed to track trends and although gaining attention, there are few prevention programmes.
25,27
Stroke Compared with individuals in high-income countries, there are reports that stroke disproportionately affects Africans with more individuals affected, and at younger ages. 4, 33, 34 Stroke prevalence differs between African countries and ethnic groups, possibly due to their differing stages in the epidemiologic transition, lifestyle factors and health-care access. 4 Stroke studies from SSA have been largely hospital based, 4, 34 apart from the few studies we list in Table 3 . In one large study, age-standardized incidence of stroke in rural Tanzania was similar to that seen in high-income countries, and in the urban location was higher than among African Americans in Manhattan. 35 The high rates of stroke appear related, at least in part, to both high rates of hypertension and its poor treatment and control in SSA. Hypertension is the most important predictor of stroke in SSA, accounting for 51% of the population attributable fraction. 33 One systematic review of 25 studies conducted in 10 SSA countries found that the prevalence of hypertension ranged from 6 to 16%, and was consistently higher in urban areas. 36 We found that hypertension prevalence reported in community-based studies ranged from 6% in rural Tanzania to 68% in a Nigerian stroke registry, and was similar among both men and women (Table  5 ). Although it is higher among older age groups 36 , prevalence ranges from 6 to 22% in South Africa and Ghana have been reported in children, similar to those in the USA and Europe. 37 Several risk factors may be related to hypertension in SSA. Reports of higher sodium intake and salt sensitivity among Black populations need further examination. [38] [39] [40] Body mass index (BMI), increasing in SSA, showed varying associations with elevated blood pressure. 41 Awareness and treatment for hypertension are low. In one review, the majority of persons with clinical hypertension had not been previously diagnosed, and of those who had been diagnosed, only 30% were currently on treatment. 36 Treatment studies are currently lacking.
Overweight, obesity and diabetes mellitus
In SSA, there is a complex relationship between underweight and overweight. In South Africa, the prevalence of underweight, stunting and wasting in children is 9, 23 and 3%, respectively. 42 Yet community studies have found approximately one-third of adult women to be obese (Table 5) . Other countries such as Nigeria, Ethiopia and Tanzania show lower obesity prevalence (Table 5 ). Abdominal obesity contributes significantly to CVD in the region. 14 Diabetes prevalence in Africa varies widely among regions, countries, populations, methods and diagnostic criteria (Table 4) . Community directly measured prevalence ranges from 2.5% in STEPS-Seychelles to 16% in STEPS-DRCongo. 43 In rural settings alone, values range from 0% in Togo or Sierra Leona, to 1.9% in STEPS-Algeria. Urban values range from 2.4% in Sierra Leona, to 8.1% in Uganda. There were an estimated 10.8 million diabetic Africans in 2006. [44] [45] [46] [47] [48] However, this is likely under-estimated since some rural screening programmes found that up to 85% of cases were undiagnosed. 49, 50 Complications of poorly treated diabetes are common in SSA (Table 6 ). Prevalence of retinopathy among diabetic patients ranges from 14 51 to 46% 52 , and up to 25% have retinopathy at diagnosis. 58 Nephropathy is present in 8 51 to 49% 53 of diabetic patients, neuropathy in 11 54 to 66% 55 and diabetic foot in 6 56 to 14% 57 . Advanced peripheral organ damage and its interaction with infections could explain why 53% of diabetic patients admitted with diabetic foot ulcer to a Lagos hospital died during admission. 63 Finally, the prevalence of risk factors present in diabetic patients (from hospital crosssectional studies in Table 6 ) are hypertension (range 24-80%), dyslypidemia (range 16-89%), overweight (range 50-83%) and obesity (29-66%).
Two characteristics of diabetes in SSA add to its morbidity and mortality. Firstly, the lack of health resources leads to late diagnosis 58, 59 and severe vascular complications 60 . Secondly, there is generally poor blood glucose control. Frequent hypoglycaemic and hyperglycaemic episodes occur with irregular meals among poor populations. 61 Prevalence is predicted to increase 80% in 20 years, and the number of affected individuals is expected to reach 18.7 million by 2025. 44 Studies from Tanzania and Cameroon showed up to a 10-fold increase in diabetes prevalence during the last 10 years.
62,64
Cancer Projections for cancer incidence from 2010 to 2030 in SSA show steep increases across all ages (Figure 2) . This rise over the coming years will be due to population aging, increases in smoking and obesity, changes in reproductive patterns and the HIV epidemic, which has increased the incidence of Kaposi's sarcoma (KS) for example, by up to 20 times. 3, 65, 66 Furthermore, WHO data show that the proportion of total cancer deaths is expected to more than double in 20 years. 7 However, we lack an understanding of the true burden and incidence of cancer in SSA. The most recent cancer incidence data from the WHO/IARC database 67 only contains information from five African countries: Egypt, Algeria, Tunisia, Uganda and Zimbabwe (Table 7) , and cancer registries cover only 11% of the population overall. 3 The cancer types with the highest incidence in Africa are breast, cervix, liver and prostate (Figure 3) , although no data were reported for KS. Furthermore, mortality was high. In Africa, 80% of women with breast cancer present at advanced stages; 65 in high-income countries only 15% do so. 68 Among women in Africa, the lifetime risk of dying from cancer is almost double that of women in high-income countries. 3 Yet, in SSA there is widespread lack of awareness, and access to screening, diagnosis and treatment. 65, 69 Research so far has indicated that family history, socio-economic status, geography, race, high BMI, reproductive and hormonal factors are related to breast cancer risk in Africa, but diet does not appear to be. 3, 65, 70, 71 Increased tobacco use will likely increase the incidence of tobacco-related cancers such as lung, oral, oesophagus, pancreas, kidney and bladder, as well as chronic obstructive pulmonary disease (COPD).
Over one-third of cancers in Africa are related to infectious conditions, double the average for the rest of the world. 3 Other known risk factors include Aflatoxin B1, a liver carcinogen produced by molds that commonly contaminates stored staple foods, 65, 72 and endemic malaria associated with Burkitt's lymphoma. 3, 73 Despite the projected increases in cancer incidence, Africa has the lowest number of per capita radiotherapy facilities in the world. 65, 68 Thirty-three African countries representing a population of 177 million persons have no access to radiotherapy. 68 
Discussion
NCD research in SSA has been negligible compared with that conducted in high-income countries, and the vast majority of published studies have been conducted in hospital or clinic settings. Our search of the literature for studies on prevalence or incidence for heart diseases, stroke, diabetes mellitus type 2, cancer and their risk factors documented results from only 13 of 45 SSA countries. Nevertheless, indications from some community-based studies are that NCDs and their risk factors have high prevalence in ASR, age-standardized rate; standardized to world population. All data were reported between 1998-2002 with the exception of Egypt, which was from 1999-2002. 67 . SSA. The scarcity of this research is likely due to a lack of funding from international organizations, institutions and local governments, as well as a shortage of scientific training and capacity in the core sciences of public health. [74] [75] [76] We conclude that action is urgently needed to mitigate the burgeoning epidemic of NCDs in Africa. Because resources for treatment will remain hugely inadequate for the foreseeable future, only primary prevention can protect public health, thereby allowing continued economic development. A wealth of evidence is ready for immediate implementation, such as hepatitis-B and HPV vaccination, tobacco control and comprehensive programmes to prevent obesity. In addition, large-scale research programmes need to investigate the specific causes-environmental and genetic-of NCDs on this gigantic, diverse continent, which is undergoing a rapid transition in lifestyle.
Country-specific estimates of morbidity and mortality due to different risk factors and diseases are invaluable for indicating disease trends and prioritizing the allocation of limited resources. Accurate and reliable assessments on the causes of death at a population level are made difficult by the low access to heath-care services in many SSA countries. Compounding this is a lack of comprehensive, community-or population-based studies on NCDs, their risk factors and etiology. Estimates for SSA compiled by the WHO are often based on very limited data. 5, 77 Currently, only sparse data on NCD risk factors such as tobacco use, physical activity, dietary quality and quantity, environmental and social risk factors, early childhood exposures, adiposity, hypertension and lipid levels are available for the region. 1, 5, 6, 21, 36, 65, 78, 79 Nationally representative cross-sectional demographic and health surveys (DHS) are conducted in several SSA countries every 5 years, and some have collected data relevant to NCDs.
80,81
Similarly, community-based longitudinal demographic surveillance sites (DSS), which exist in 12 African nations, collect NCD data in addition to their standard information on births, deaths by verbal autopsy and migrations of defined populations. [82] [83] [84] Both the size and national representativeness of these and epidemiologic studies has varied widely, but have provided important information on changes in the major causes of death and indications of disease trends. 14, 21, 34, 36, 84, 85 For example, data from one DSS cohort in South Africa showed that four of the top five most common causes of death in adults 550 years are non-communicable conditions. 84 The WHO STEPwise approach to surveillance has attempted to make data on NCDs comparable across countries by supporting standardized questions and protocols to monitor trends. Questionnaires have both short and longer versions and leave flexibility for countryspecific information. 86 Limitations of our review are that our inclusion criteria for manuscripts to those published in English may have missed studies that presented results in another language (notably French or Portuguese). Additionally, we used only the PubMed database for our search which may have excluded publications which were not in this database. Despite these limitations we feel that the data we have presented reflect the comparatively sparse data for NCDs in SSA, although for some countries (e.g. South Africa) good quality data from multiple studies in the community exist. 
67
Addressing the NCD epidemic in SSA The simultaneous infectious and NCD burden in SSA, as well as lifestyle, cultural and genetic differences, mean that results from high-income countries cannot be applied indiscriminately to the African context. 87 In the absence of vital statistics systems, epidemiologic studies with a variety of designs and capable of in-depth analyses of risk factors and the effects of interventions could provide a better understanding of NCDs in SSA, and provide information critical to health-care policy decision making. 75 Research priorities for the region should include: (i) better quantification of the NCD burden; (ii) aetiologic evidence for locally important risk factors; (iii) identification of successful interventions for low-income settings; and (iv) the use of innovative technologies to spur research, interventions and treatment. There is a clear need for a comprehensive investigation of the true incidence of CVD, cancer, diabetes mellitus and their risk factors in SSA. Studies conducted in communities rather than in hospitals will provide more accurate estimations by taking into account the population who do not access health services.
Aetiologic studies that examine the relative importance of known and yet unknown risk factors are urgently needed, as they would expand our evidence base for defining at-risk populations and for designing effective primary prevention and treatment programmes. The high prevalence of communicable diseases in SSA presents a unique opportunity to study the interactions between communicable and NCDs, such as the impact of chronic infection on the incidence of NCDs. Furthermore, discoveries made in SSA on environmental and genetic causes of NCDs could have broader global relevance. 87 Increased diagnoses of NCDs will lead to a corresponding need for health services capacity, which are currently over-stretched, to diagnose and treat these conditions, and for aggressive primary prevention programmes, as late diagnoses lead to poorer health outcomes. Intervention trials for both prevention and treatment of NCDs could further provide data for local priority setting. For example, a community-based trial in Ghana to reduce salt intake resulted in decreased systolic blood pressure, and could be explored more widely. 88 Treatment options for cancer in particular are limited in SSA. Radiotherapy is indicated for 55% of new cancer cases in Africa, 68 but is often unavailable, or prohibitively expensive. In one small study in Nigeria, the few patients who could afford cervical cancer treatment spent almost 30% of their annual income on it. 89 Thus, primary prevention may be the best way of reducing cancer's burden in SSA. In countries with WHO data, negligible proportions of women have had mammography or PAP smears. 79 Increasing access to Hepatitis B vaccination, 65 Human Papilloma Virus (HPV) testing, 90 HPV vaccination when affordable 91 and ensuring blood and injection safety are important for cancer prevention. Growing awareness, legislative measures (e.g. tobacco taxation) and health promoting messages can encourage healthy behaviour and could attenuate rising cancer incidence in SSA. One study among Ghanaian civil servants found a decrease in smoking prevalence among both men (from 32 to 6%) and women (from 6 to 3%) between 1976 and 2006. 92 The use of innovative technologies for research, interventions and programme implementation could simplify and facilitate NCD research in SSA. For example, cell phone technology has rapid penetration in the African continent 93 and untapped potential to access influential social networks for beneficial public health messages. The ease and value of this communication has reached the most remote rural villages, even those without electricity. The application of cell phone technology to public health is only nascent and has far-reaching possibilities. Cell phones have been used to help children with diabetes track their glucose levels, physical activity and food intake-in a randomized trial those with the cell phone intervention had better diabetes knowledge and less hyperglycemia than controls. 94 Adoption of healthy behaviour patterns may most effectively occur through reinforcing health-conscious social networks, and with the capacity to easily reach millions of users, there is the potential to easily, quickly and flexibly test many randomized interventions.
Training in all fields of health sciences is urgently needed in SSA. A secondary advantage of conducting epidemiologic research is the scientific training and capacity building that it engenders. Operations research and training, and improved, integrated service delivery should ideally be developed in tandem with epidemiologic research to provide a holistic approach to addressing the myriad, often interacting, communicable and non-communicable conditions in SSA.
In conclusion, the prevalence of NCDs in SSA is high even with probable under-reporting, and will certainly increase in coming years. SSA is at a unique juncture in history where opposites such as infectious and chronic conditions, starvation and overweight, subsistence farming and economic development co-exist. We believe that proactive thinking is essential in order to mitigate the effects of this burgeoning epidemic, and to provide critical data for formulating evidence-based health policy and interventions. Epidemiologic studies that accurately measure disease prevalence, incidence, aetiology, and effective prevention and treatment methods will provide not only much needed public health information for SSA, but could help towards building a strong, sustainable, scientific base for training the next generation of African public health scientists.
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KEY MESSAGES
Available data and projections indicate that the burden of NCDs such as cardiovascular diseases, diabetes mellitus type 2 and cancer is growing in SSA. Yet, there are few community-based studies that examine the NCD prevalence, incidence and risk factors.
In some African settings the prevalence of NCDs and their risk factors is similar to that seen in developed countries.
More research is needed in Africa to provide evidence for NCD prevention and treatment to mitigate the oncoming epidemic.
